Skip to main content
. 2025 Jan 21;20(1):6. doi: 10.5334/gh.1390

Table 4.

Study outcomes: between groups comparison.


OUTCOME GROUP n UNADJUSTED ANALYSIS VIA t TEST ADJUSTED ANALYSIS VIA ANCOVA


MEAN SD 95% CI p-VALUE1 MEAN 95% CI p-VALUE2

Office SBP (V2 – V1) Control 36 –0.56 17.26 (–6.4; 5.29) 0.047 –0.38 (–5.56; 4.81) 0.063

Intervention 39 –7.60 12.71 (–11.7; –3.48) –7.37 (–12.96; –1.79)

Office DBP (V2 – V1) Control 36 4.38 7.51 (1.83; 6.91) 0.102 4.49 (1.72; 7.27) 0.031

Intervention 39 1.19 8.98 (–1.72; 4.1) 0.14 (–2.85; 3.13)

Central SBP (V2 – V1) Control 36 1.38 14.88 (–3.65; 6.41) 0.078 1.77 (–2.71; 6.25) 0.038

Intervention 39 –4.10 11.62 (–7.87; –0.34) –5.00 (–9.82; –0.17)

Central DBP (V2 – V1) Control 36 –1.15 10.56 (–4.7; 2.43) 0.824 –1.06 (–4.13; 2.00) 0.684

Intervention 39 –0.68 7.71 (–3.17; 1.82) –1.96 (–5.26; 1.34)

HBPM SBP (V2 – V1) Control 36 0.39 6.84 (–1.93; 2.70) 0.293 0.68 (–1.84; 3.20) 0.579

Intervention 39 –1.44 7.98 (–4.02; 1.15) –0.32 (–3.04; 2.39)

HBPM DBP (V2 – V1) Control 36 0.42 5.27 (–1.37; 2.2) 0.535 0.52 (–1.20; 2.25) 0.722

Intervention 39 –0.31 4.80 (–1.86; 1.25) 0.09 (–1.77; 1.94)

PWV (V2 – V1) Control 36 0.15 0.62 (–0.06; 0.36) 0.155 0.17 (–0.03; 0.37) 0.134

Intervention 39 –0.05 0.55 (–0.22; 0.13) –0.04 (–0.25; 0.17)

FMD (V2 – V1) Control 36 –3.34 8.90 (–6.36; –0.33) <0.001 –3.01 (–5.95; –0.07) <0.001

Intervention 39 4.12 8.35 (1.41; 6.82) 4.94 (1.77; 8.11)

1p-value from unpaired two-samples t-test with equal variance; 2p-value from ANCOVA models adjusted for gender and BMI (baseline).

SD – standard deviation, V1 – initial visit, V2 – final visit, SBP - systolic blood pressure, DBP - diastolic blood pressure, HBPM – home blood pressure measurement, PWV – pulse wave velocity, FMD – flow mediated dilation.